Login to Your Account



New high-performance Alzheimer's disease biomarkers developed

By John Fox
Staff Writer

Thursday, February 8, 2018

The first high-performance plasma biomarkers for Alzheimer's disease (AD) have been validated in an international collaborative study, which was reported in the Jan. 31, 2018, edition of Nature.

To continue reading subscribe now to Science News

Learn More about Science News

Already a subscriber? Sign In or Buy now to activate your subscription